Odunsi K - Search Results

1

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.

McGray AJR, Huang RY, Battaglia S, Eppolito C, Miliotto A, Stephenson KB, Lugade AA, Webster G, Lichty BD, Seshadri M, Kozbor D, Odunsi K. McGray AJR, et al. Among authors: odunsi k. J Immunother Cancer. 2019 Jul 17;7(1):189. doi: 10.1186/s40425-019-0641-x. J Immunother Cancer. 2019. PMID: 31315674 Free PMC article.

2

Tumor antigens and markers for breast and ovarian cancers.

Ghadersohi A, Chitta K, Greco WR, Harvey S, Winston J, Slocum H, Odunsi K, Sood AK. Ghadersohi A, et al. Among authors: odunsi k. Front Biosci. 2002 Feb 1;7:e48-57. doi: 10.2741/ghader. Front Biosci. 2002. PMID: 11815284 Review.

3

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. Tammela J, et al. Among authors: odunsi k. Cancer Immun. 2004 Oct 18;4:10. Cancer Immun. 2004. PMID: 15487888

4

Vaccine therapy for cancer: fact or fiction?

Odunsi K, Lele S, Savalgi R. Odunsi K, et al. Surg Technol Int. 2004;13:39-47. Surg Technol Int. 2004. PMID: 15744673 Review.

5

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K. Hylander B, et al. Among authors: odunsi k. Gynecol Oncol. 2006 Apr;101(1):12-7. doi: 10.1016/j.ygyno.2005.09.052. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16263157

6

IL-12-programmed long-term CD8+ T cell responses require STAT4.

Li Q, Eppolito C, Odunsi K, Shrikant PA. Li Q, et al. Among authors: odunsi k. J Immunol. 2006 Dec 1;177(11):7618-25. doi: 10.4049/jimmunol.177.11.7618. J Immunol. 2006. PMID: 17114431

7

Harnessing the immune system for ovarian cancer therapy.

Odunsi K, Sabbatini P. Odunsi K, et al. Am J Reprod Immunol. 2008 Jan;59(1):62-74. doi: 10.1111/j.1600-0897.2007.00560.x. Am J Reprod Immunol. 2008. PMID: 18154597 Review.

8

Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.

Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Matsuzaki J, et al. Among authors: odunsi k. Cancer Immunol Immunother. 2008 Aug;57(8):1185-95. doi: 10.1007/s00262-008-0450-4. Epub 2008 Feb 6. Cancer Immunol Immunother. 2008. PMID: 18253733 Free PMC article.

9

Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.

Tchabo NE, Mhawech-Fauceglia P, Caballero OL, Villella J, Beck AF, Miliotto AJ, Liao J, Andrews C, Lele S, Old LJ, Odunsi K. Tchabo NE, et al. Among authors: odunsi k. Cancer Immun. 2009 Aug 26;9:6. Cancer Immun. 2009. PMID: 19705800 Free PMC article.

10

Antigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses.

Li Q, Eppolito C, Odunsi K, Shrikant PA. Li Q, et al. Among authors: odunsi k. J Leukoc Biol. 2010 Feb;87(2):257-63. doi: 10.1189/jlb.0409221. Epub 2009 Oct 20. J Leukoc Biol. 2010. PMID: 19843578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page